Allergan Gains Sanctura XR Rights With Esprit Purchase
This article was originally published in The Pink Sheet Daily
Executive Summary
Indevus is in “a far stronger marketing position” for the overactive bladder product under a new license agreement with Allergan, Indevus CEO says.